LUNG Pulmonx Corporation
Healthcare$1.52+0.00%OpenMarket Cap: $64.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.42
P/S
0.74
EV/EBITDA
-1.22
DCF Value
$-13.94
FCF Yield
-45.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.5%
Operating Margin
-58.8%
Net Margin
-60.1%
ROE
-92.9%
ROA
-44.4%
ROIC
-50.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $20.6M | 77.9% | $-13.0M | $-13.7M | $— | — |
| Q4 null | $22.6M | 77.6% | $-9.9M | $-10.4M | $— | — |
| FY null | $90.5M | 74.2% | $-53.7M | $-54.0M | $— | — |
| Q3 null | $21.5M | 74.7% | $-14.4M | $-14.0M | $— | — |
| Q2 null | $23.9M | 72.1% | $-14.8M | $-15.2M | $— | — |
| Q1 null | $22.5M | 72.5% | $-14.6M | $-14.4M | $— | — |
| Q4 null | $23.8M | 74.0% | $-13.4M | $-13.2M | $— | — |
| FY null | $83.8M | 74.0% | $-57.7M | $-56.4M | $— | — |
| Q3 null | $20.4M | 73.7% | $-14.1M | $-14.1M | $— | — |
| Q2 null | $20.8M | 73.7% | $-15.6M | $-15.3M | $— | — |
| Q1 null | $18.9M | 74.1% | $-14.5M | $-13.7M | $— | — |
| Q4 2023 | $19.3M | 74.2% | $-13.9M | $-13.9M | $-0.36 | — |